Oculus Innovative Sciences Announces Corporate Name Change to Sonoma Pharmaceuticals, Inc. and New NASDAQ Ticker Symbol to Better Align with Dermatology Focus
05 déc. 2016 05h05 HE
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions for the...
Oculus Innovative Sciences Reports Financial Results for Fiscal Second Quarter 2017
10 nov. 2016 16h05 HE
|
Oculus Innovative Sciences, Inc.
U.S. Product Revenue up 43%, Driven by Growth in U.S. Dermatology Oculus Announced Sale of Latin America Assets for $19.5 Million in Cash (see separate press release, issued on October 31,...
Oculus Innovative Sciences Sells Latin America Business to Invekra S.A.P.I. de C.V. for $19.5 Million in Cash
31 oct. 2016 16h05 HE
|
Oculus Innovative Sciences, Inc.
Total cash consideration for sale of Latin American business (which is 30% of current Oculus revenue) exceeds Oculus’ current market capitalization of $17 million U.S.Transaction further includes...
Oculus Innovative Sciences Announces Fiscal Second Quarter 2017 Financial Results and Conference Call
27 oct. 2016 04h05 HE
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal second quarter 2017,...
Oculus Innovative Sciences Launches Lasercyn™ into U.S. Dermatology Market for Use Following Laser Procedures, Microdermabrasions and Chemical Peels
30 août 2016 04h05 HE
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., Aug. 30, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets solutions...
Oculus Innovative Sciences Receives Australian Approvals to Market Sterile Microcyn®-Based Antimicrobial Solutions and Hydrogel Dressings
11 août 2016 04h05 HE
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), a specialty pharmaceutical company that develops and markets unique and...
Oculus Innovative Sciences Announces Fiscal First Quarter 2017 Financial Results and Conference Call
19 juil. 2016 04h05 HE
|
Oculus Innovative Sciences, Inc.
PETALUMA, Calif., July 19, 2016 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (NASDAQ: OCLS, warrants OCLSW), today announced that the financial results for its fiscal first quarter 2017,...